Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan

CHUN-JU CHIANGJhuang, Jing-RongJing-RongJhuangYang, Ya-WenYa-WenYangZhuang, Bo-ZhiBo-ZhiZhuangYou, San-LinSan-LinYouWEN-CHUNG LEEChen, Chien-JenChien-JenChen2023-03-172023-03-172022-07-012574-3805https://scholars.lib.ntu.edu.tw/handle/123456789/629374Chronic infections of hepatitis B and C viruses are the main causes of end-stage liver disease (ESLD) worldwide. The successful control of viral hepatitis is critical to reducing the burden of ESLD.enHEPATOCELLULAR-CARCINOMA; VIRUS-INFECTION; AGE-PERIOD; TEMPORAL VARIATION; MORTALITY TRENDS; SECULAR TRENDS; CANCER RATES; RISK-FACTORS; TRANSMISSION; PREVALENCEAssociation of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwanjournal article10.1001/jamanetworkopen.2022.22367358493942-s2.0-85134519917WOS:000828792800008https://api.elsevier.com/content/abstract/scopus_id/85134519917